Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and activating dCK
Background: Previously, our investigations have underscored the potential of hyperthermia to improve the therapeutic efficacy of gemcitabine (GEM) in pancreatic cancer (PC). Nonetheless, the precise underlying mechanisms remain elusive. Methods: We engineered two GEM-resistant PC cell lines (BxPC-3/...
Main Authors: | Qiaoxian He, Yangyang Zheng, Lei Lu, Hongzhang Shen, Weigang Gu, Jianfeng Yang, Xiaofeng Zhang, Hangbin Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024045195 |
Similar Items
-
Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway
by: Darius Stukas, et al.
Published: (2023-08-01) -
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
by: Hai Yang, et al.
Published: (2022-06-01) -
Hyperthermia-Triggered Gemcitabine Release from Polymer-Coated Magnetite Nanoparticles
by: G. R. Iglesias, et al.
Published: (2018-03-01) -
Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
by: Xiangyu Zhao, et al.
Published: (2022-08-01) -
EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
by: Peng Zheng, et al.
Published: (2022-01-01)